BLTE - CIK 0001889109
No parsed quarterly data available for BELITE BIO, INC yet.
BELITE BIO, INC reported operating cash flow of -$36.99M for fiscal year 2025. That is down 26.5% from -$29.23M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$4.44M (FY 2020) to -$36.99M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.